UKMF

Past Meetings

• 22 Mar 2017 — UKMF Spring Day 2017[ + ]

  The theme for the UKMF Spring Day will be, Personalised therapy in myeloma: Fact or Fiction? 

  • Michael Morley Lecture:  Understanding the myeloma environment by Irene Ghobrial                                                                          
  •  Patients Case histories
  • Topics: Driver mutations, MRD testing, Hevylite assays, Frailty biomarkers
  • Biomarkers for personalised therapy in Myeloma
  • ASH Bursary winners
  • Eric Low – tribute to former Myeloma UK Chief Executive

  If you would like to register for this event, please visit http://www.hartleytaylor.co.uk or contact Wendy@ukmf.org.uk

  • Spring Day Programme — UKMF
  • Making sense of prognostic factors — Dean Smith
  • Actionable/driver mutations in myeloma — Mike Chapman
  • Hevylite assays de-convoluted — Karthik Ramasamy
  • MRD testing:which platforms, which patients? — Roger Owen
  • The patient's perspective — Eric Low
  • Frailty Biomarkers — Prof Gordon Cook
• 09 Nov 2016 — UKMF Autumn Day 2016[ + ]

   

  The theme for the UKMF Autumn Day on 9th November 2016 was ‘Next Generation Therapies in Myeloma’.

  We were delighted to welcome Prof Sagar Lonial (Atlanta, USA), who presented the Michael Morley lecture on ‘Treatment of Myeloma with monoclonal antibodies’is open for registration.

   

  Talks can be downloaded below.

   

  • Autumn Day Programme 9th November 2016 — Karthik Ramasamy
  • Treatment of myeloma with monoclonal antibodies — Prof Sagar Lonial
  • New Proteasome inhibitors in myeloma — Dr Holger Auner
  • NICE guidance MM - practice implications — Dr Guy Pratt
  • What is high risk myeloma? Challenging case studies — Dr Ceri Bygrave
  • Challenging cases - double refractory MM and clinical overview of anti CD38 monoclonal antibodies — Dr Rachel Hall
  • Immunotherapy in myeloma, where do we go? — Prof Paul Moss
  • New agents in MM presenting / relapsing with renal impairmen — Karthik Ramasamy
• 20 Apr 2016 — BSH/ UKMF Symposium – April 2016, Glasgow[ + ]

  The BSH/ UKMF joint symposium at the SECC in Glasgow in April 2016 was a huge success. The theme for the symposium, was ‘Understanding Risk in Myeloma: A practical approach’.  Prof Kwee Yong and Dr Karthik Ramasamy were the session Chairs. Guest international speakers included, Phillipe Moreau (France), Sonja Sweegman (The Netherlands) and Wee Joo Chng (Singapore).

  

  

  • Risk Stratification in the older patient; what are our priorities — Dr Sonja Sweegman
  • Integrating NGS approaches into patient care: How I manage high-risk disease at presentation in a transplant eligible patient — Prof Chung Wee Joo
  • High-risk smoldering myeloma — Philippe Moreau
• 17 Mar 2016 — UKMF Spring Day 2016[ + ]

  The Spring Day had a record turn out. Talks will be available to download from this site.

  Special thanks to all our guest speakers, especially to Dr Peter Croucher, who flew from Australia to give an excellent talk on Mechanisms of bone loss in Multiple Myeloma: an increasingly important role for bone cells.

  

  • UKMF Spring Day Programme 17th March 2016 — Jenny Bird
  • Challenging Cases — Dr Neil Rabin
  • Evidence for use of CT scanning and PET-CT in managing patients with Myeloma — Dr Elena Zamagni
  • Quantitative whole-body MRI for treatment response monitoring in Multiple Myeloma — Dr Arash Latifoltojar
  • Exercise and Physiotherapy in Myeloma — Orla McCourt
  • Osteonecrosis of the jaws — Stefano Fedele
  • Bone Pain: A Practical Approach to Management — Dr Rowan Hearn
• 04 Nov 2015 — UKMF Autumn Day 2015[ + ]

  Thank you to everyone who attended this meeting. We are grateful to our sponsors and delegates and by the numbers and feedback, we are delighted that this event was a huge success.

  The theme for this meeting was ‘Myeloma: The Challenge of Communicating Complex Data’.

  The Michael Morley lecture will be presented by Prof. Faith Davies from the University of Arkansas.

  The registration fee for the UKMF Spring and Autumn Days are £60. There is a discount fee of £40 available for scientists and nurses.

  A copy of the programme can be downloaded below.

  To register on line, click here http://www.hartleytaylor-registration.co.uk/hartley/registration.aspx?id=UKM1

  • Autumn Day 2015 Programme — Roger Owen
  • Frailty, salvage ASCT and AlloSCT: — Prof Gordon Cook
  • What is the most effective method of preventing bone disease in patients with myeloma? — Guy Pratt
  • Hierarchical Cluster analysis of Florescent in Situ Hybridisation in newly diagnosed myeloma patients — Ieuan Walker
  • Guidelines for the correct determination of second primary malignancies (SPM) in myeloma trails — John Jones
  • Lisa Crawford — The E3 ligase HUWE1 is a potential therapeutic target in Multiple Myeloma
  • Pomalidomide Talk — Nicola Maciocia
  • Bleeding diathesis, thrombotic tendencies and endothelial dysfunction in systemic AL patients — Shameem Mahmood
  • Bendamustine therapy in MM — Karthik Ramasamy
• 19 Mar 2015 — UKMF Spring Day 2015[ + ]

  The UKMF Spring Day was held on 19th March 2015 at SOAS, central London. A copy of the programme and most of the talks can be downloaded below.

  Thank you to all the UKMF sponsors for their continued support.

   

  UKMF Chair, Dr Jenny Bird with international guest speakers, Prof Keith Stewart and Dr Ramon Garcia-Sanz

  • UKMF Spring Day 15 Programme — Prof Graham Jackson
  • Genomic Guided Therapy in Myeloma — Prof Keith Stewart
  • Minimal residual disease in multiple myeloma by next generation sequencing — Dr Ramon Garcia-Sanz
  • Paraproteins and response assessments - – what have we learnt from MRC trials? — Prof Mark Drayson
  • multiple myeloma: D-type cyclin and PI3k pathways — Prof Kwee Yong
  • MRD in myeloma — Dr Roger Owen
  • The extent of intra-clonal genetic diversity within the myeloma clone is a predictive biomarker of progression and outcome after treatment — Dr Lorenzo Melchor
  • Flow-cytometric quantification of minimal residual disease (MRD) in myeloma: independent outcome prediction & sequential survival benefits per log tumour reduction — Dr Andy Rawstron
  • Targeting RAS pathways in myeloma — Dr Martin Kaiser
• 12 Nov 2014 — Autumn Day 2014[ + ]

  The theme for the 2014 Autumn day was ‘New developments in Myeloma’.

  We were delighted to announce a full programme with the Michael Morley guest speaker from the Mayo clinic, Professor Angela Dispenzieri, who presented a lecture entitled, “Benign monoclonal gammoapthy. How benign is it really?”

  Please see programme for more information.

  Nearly 200 delegates attended, making this the most successful UKMF Autumn Day yet.

  

  Here is the UKMF Chair, Dr Jenny Bird presenting a certificate to the Michael Morley guest speaker, Dr Angela Dispenzieri at the Autumn Day 2014.

   

   

  • UKMF Autumn Day Programme Nov 2014 — Guy Pratt
  • Benign monocional gammopathy: how benign is it really? — Prof Angela Dispenzieri
  • The place of newer imaging techniques in multiple myeloma — Dr Andrew Chantry
  • Stem Cell Transplantation in Myeloma — Prof Gordon Cook
  • Genetic subtyping of Myeloma — Dr Martin Kaiser
  • How to manage high risk myeloma — Dr Matthew Jenner
  • Management of Myeloma Spinal Disease — Mr Sean Malloy
  • A Pomalidomide Update — Dr Matthew Streetly
• 19 Mar 2014 — UK Myeloma Forum Spring Day 2014[ + ]

  Thank you to all our presenters, guests and sponsors who attended the UKMF Spring Day 2014 and making the day a huge success.

  The theme was  ‘The immunology of myeloma and paraproteinaemia’. A copy of the programme can be downloaded on this page.

  The Michael Morley speaker was the newly retired, Dr Fiona Ross. She gave a talk entitled ‘Myeloma cytogenetics: a personal and historical perspective’, which was very well received.

  The presentations can be downloaded from this page.

   

   

  • Programme Spring Day 2014 — WN
  • Myeloma cytogenetics: a personal and historical perspective — Fiona Ross
  • Cold Agglutinin Disease — Sigbjorn Berentsen
  • Management of IgM-related diseases — Veronique Leblond
  • Humoral immune deficiency and immune reconsititution in myeloma — Mark Drayson
  • Clinical management of secondary antibody deficiency (SAD) — Sinisa Savic
  • MYC Translocations In Multiple Myeloma Involve Recruitment Of Enhancer Elements Resulting In Over- Expression and Decreased Overall Survival — Brian Walker
  • A rapid and robust molecular diagnostic approach for multiple myeloma — Martin Kaiser
  • Use of plasma cell immunophenotype as prognostic markers in patients with systemic AL amyloidosis — Sajitha Sachchithanantham
  • Challenges facing An.-­‐tumour Immunotherapy in Myeloma — Gordon Cook
• 14 Nov 2013 — UK Myeloma Forum Autumn Day[ + ]

  Thank you to everyone who took part and supported this UKMF.

  The theme for this event was ‘Myeloma in the Elderly’. The Michael Morley lecture was kindly given by  Prof Heniz Ludwig, Centre for Oncology, Haematology and Palliative Care at Wilhelminenspital, Vienna.

  Please see attached programme and talks.

   

  • Programme Autumn Day 14 Nov 2013 — Dr Stella Bowcock
  • What we know about myeloma in elderly patients from trials and observational studies? — Heinz Ludwig
  • Comprehensive geriatric assessment in older people undergoing cancer treatment — Danielle Harari
  • The Role of Cytogenetics in Elderly patients with Myeloma — Faith Davies
  • An Oncologist’s guide to Dementia & Delirium — Mark Kinirons
  • CPC vignettes – challenging cases in the elderly — Neil Rabin
  • The challenges of managing myeloma in the elderly — Stella Bowcock
• 13 Mar 2013 — UK Myeloma Forum Spring Day[ + ]

  The UK Myeloma Forum Spring Day was on Wednesday 13th March 2013 at the Society of Oriental and African Studies, London.

  This years meeting will be built around the theme of targeted biological approaches.

  Prof Chen-Kiang from Cornell University in New York, an International expert in the way myeloma plasma cells divide and grow (cell cycle) give the Michael Morley lecture.

  The programme and talks for this event can be downloaded below.

   

   

   

   

  • Programme UKMF Spring Day 13 March 2013 — Kwee Yong
  • Targeting the Cell Cycle in Multiple Myeloma — Selina Chen-Kiang
  • Targeting the protein processing machinery — Faith Davis
  • Developing TCR gene therapy — Gavin Bendle
  • Early Phase Myeloma Studies — Rakesh Popat
  • Survival signalling in myeloma — Asim Khwaja
  • Unpicking the Targets in Multiple Myeloma — Kwee Yong
  • Early Phase Clinical Trial Network — Heather McKinnon
  • Clinical Drug Resistance Linked to Inter-convertible Phenotypic and Functional States of Tumour-Propagating cells in Multiple Myeloma — Aristeidis Chaidos
  • The Impact of Thalidomide Maintenance Therapy Varies According to Biological Risk Grouping — Annamaria Brioli
  • Intra-clonal heterogeneity is a critical early event in the preclinical stages of — Lorenzo Melchor
  • Stable epigenetic reprogramming of bone marrow MSC in patients with MM — Sarah Essex